| Dean Mcgee Eye Institute Optical Se | |
| 3500 Nw 56th St, Oklahoma City, Oklahoma 73112 | |
| (405) 271-9506 |
| Name | Dean Mcgee Eye Institute Optical Se |
|---|---|
| Organization Name | Dean Mcgee Eye Institute |
| Location | 3500 Nw 56th St, Oklahoma City, Oklahoma 73112 |
| Type | Supplier |
| Phone | (405) 271-9506 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.
A review by RCSI University of Medicine and Health Sciences in collaboration with the HSE National Quality Improvement Team has found that quality improvement (QI) studies in Ireland over a five-year period conformed to high reporting standards and enhanced multiple elements of healthcare quality.
› Verified 9 days ago
News Archive
A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
AB SCIEX, a global leader in life science analytical technologies, today announced the introduction of the AB SCIEX 4500 series, which is next-generation, mass spectrometry instrumentation that sets a new benchmark for routine quantitation and screening.
A review by RCSI University of Medicine and Health Sciences in collaboration with the HSE National Quality Improvement Team has found that quality improvement (QI) studies in Ireland over a five-year period conformed to high reporting standards and enhanced multiple elements of healthcare quality.
› Verified 9 days ago
180 Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8516 Nw Expressway, Oklahoma City, Oklahoma 73162 Phone: (877) 688-2729 | |
Rehab Medical Supply Type: Medicare Supplier Location: 4601 N May Ave, Oklahoma City, Oklahoma 73112 Phone: (405) 947-6162 | |
Accente, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11629 S Western Ave, Oklahoma City, Oklahoma 73170 Phone: (405) 703-3143 | |
Accredo Health Group, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4901 W Reno Ave, Oklahoma City, Oklahoma 73127 Phone: (405) 942-3961 | |
Aerocare Home Medical Equipment Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 6125 W Reno Ave, Ste 100, Oklahoma City, Oklahoma 73127 Phone: (405) 943-2200 |